Spotlight® Lymphoma

Spotlight® Lymphoma supports the accurate and efficient diagnosis of lymphoid malignancies. This AI-powered digital pathology solution combines advanced image analysis with expert-validated algorithms to help pathologists detect and classify lymphomas with greater speed, consistency and confidence.

It integrates seamlessly into existing laboratory workflows and provides actionable insights that reduce diagnostic variability, improve turnarounds times and support better patient outcomes. Spotlight® Lymphoma meets medical device regulatory standards.

Spotlight® Lymphoma is registered for use in the UK under UKCA (IVDR, CE mark due 2026). Combining cutting-edge technology with clinical governance, it aims to be a trusted tool for NHS laboratories and healthcare providers worldwide.

Who it supports

Spotlight® Pathology supports clinicians, laboratories, and healthcare systems by combining AI technology with clinical expertise to improve the speed, accuracy, and reliability of cancer diagnostics.

  1. NHS Pathology Laboratories
  2. Pathologists and Laboratory Scientists
  3. Healthcare Systems and Trusts
  4. Researchers and Academic Centres

30%

Improving Lymphoma diagnostic efficiency by 30%1

in-line

Performance in line with Specialist Haematopathologists2

1 - Spotlight Lymphoma internal research.
2 - Tsakiroglou, A.M et al (2024). Lymphoma triage from H&E using AI for improved clinical management, J. Clin. Pathol, 18;78(1):28-33.

Spotlight® Lymphoma is an AI-powered digital pathology tool that supports pathologists in detecting and classifying lymphoid malignancies. Working from digitised slides, it applies expert-validated image analysis to highlight regions of interest and surface consistent, quantifiable insights. It complements clinical judgement rather than replacing it - reducing variability, speeding up review, and helping teams reach confident diagnoses faster for better patient outcomes.

Spotlight® Lymphoma is built on algorithms validated against expert-reported cases, with performance assessed through rigorous testing and clinical governance managed within an ISO 13485 Quality System. By reducing inter-observer variability, it helps standardise interpretation across teams and sites. [Insert your validated concordance figures here.] Every result is confirmed by a qualified pathologist, keeping clinical accountability firmly with your team.

Yes. Spotlight® Lymphoma is designed to slot into established laboratory workflows rather than disrupt them, working alongside your existing scanners, image management systems, and reporting pathways. Integration is handled collaboratively with your IT and laboratory teams to ensure compatibility with your infrastructure and governance requirements - so adoption is straightforward, turnaround benefits arrive quickly, and there's no costly system overhaul.

Spotlight® Lymphoma is developed to meet the standards required for clinical diagnostic use, including UKCA marking and IVDR compliance, and is maintained within an ISO 13485 Quality Management System. This gives NHS laboratories assurance of recognised safety, quality, and performance standards. [Confirm current certification status before publishing.] We can provide full documentation to support procurement and clinical safety assessment.

"A pathologist with AI is better than a pathologist without AI"

  • Anil Parwani, M.D., Ph.D., M.B.A.
  • Wexner Medical Center - Department of Pathology

"Spotlight lymphoma tool enables automated triage of lymph node specimens, speeding up investigation of possible cases of lymphoma, saving pathologist time, and giving patients faster diagnosis and treatment."

  • Professor Richard Byers
  • Manchester University NHS Foundation Trust - Haematopathologist Consultant

"Spotlight work in tandem with pathologists to deliver for haematopathology. This is a complex area and the AI tool will enable triage of broad disease categories, but in the fullness of time, will enable a second opinion platform too. The team are enabling in their approach and absolute fun to work with."

  • Dr. Geetha Menon
  • Clinical Director, Cheshire & Merseyside HODS